Answers are grounded in this paper and cite their sources.
Twenty-five years after its approval by the FDA and EMA, tacrolimus remains the cornerstone of immunosuppressive treatment following solid organ transplantation [1,2]. The drug is highly effective ...
No takes yet. Share an insight, caveat, or question.
Francke et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: